SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (972)6/8/1997 5:03:00 PM
From: Brad C. Dunlap   of 1762
 
Well welcome back as I trust you thought long and hard about your decision. If you really get down to it, this is what we all have been waiting for and that is to get a product through the clinicals and into the marketplace. This should be where the fun begins. The CE9.1 situation is a difficult thought and one needs to look at all scenarios. If the worst were to happen on CE9.1 the stock would take one hec of a short term hit but IMO would create a real buying opportunity. If CE9.1 were to succeed then this would create an even more exciting situation. My personal thoughts are that the latter is the more probable outcome. I agree with your comments in regards to Mr Hecht.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News